ARTICLE | Company News
Oxford Gene, University of Oslo deal
February 27, 2012 8:00 AM UTC
Inven2, the technology transfer arm of the university, granted Oxford Gene exclusive rights to develop and commercialize 12 colorectal cancer tissue biomarkers. Oxford Gene said the biomarkers had 93%...